Similar articles

• Monocyte derived dendritic cells from HIV-1 infected individuals partially reconstitute CD4 T-cell responses.

  Newton PJ, Weller IV, Williams IG, Miller RF, Copas A, Tedder RS, Katz DR, Chain BM. Newton PJ, et al. AIDS. 2006 Jan 9;20(2):171-80. doi: 10.1097/01.aids.0000202649.95655.8c. AIDS. 2006. PMID: 16511409
• CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection.

  Lange CG, Valdez H, Medvik K, Asaad R, Lederman MM. Lange CG, et al. Clin Immunol. 2002 Feb;102(2):154-61. doi: 10.1006/clim.2001.5164. Clin Immunol. 2002. PMID: 11846457
• CD4+ lymphocyte function with early human immunodeficiency virus infection.

  [No authors listed] [No authors listed] Dis Markers. 1990 Jan-Feb;8(1):40-1. Dis Markers. 1990. PMID: 1968803 No abstract available.
• Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort.

  Ratto-Kim S, Garner RP, Kim JH, Jagodzinski LL, Michael NL, Paris R, Redfield RR, Birx DL. Ratto-Kim S, et al. J Infect Dis. 2004 Jun 1;189(11):1988-95. doi: 10.1086/386285. Epub 2004 Apr 30. J Infect Dis. 2004. PMID: 15143464
• B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.

  Cagigi A, Nilsson A, De Milito A, Chiodi F. Cagigi A, et al. Vaccine. 2008 Jun 6;26(24):3016-25. doi: 10.1016/j.vaccine.2007.11.063. Epub 2007 Dec 17. Vaccine. 2008. PMID: 18164520 Review.